The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention
Open accessAbstract
Scientists have long sought to characterize the pathophysiologic basis of schizophrenia and develop biomarkers that could identify the illness. Extensive postmortem and in vivo neuroimaging research has described the early involvement of the hippocampus in the pathophysiology of schizophrenia. In this context, we have developed a hypothesis that describes the evolution of schizophrenia—from the premorbid through the prodromal stages to syndromal psychosis—and posits dysregulation of glutamate neurotransmission beginning in the CA1 region of the hippocampus as inducing attenuated psychotic symptoms and initiating the transition to syndromal psychosis. As the illness progresses, this pathological process expands to other regions of the hippocampal circuit and projection fields in other anatomic areas including the frontal cortex, and induces an atrophic process in which hippocampal neuropil is reduced and interneurons are lost. This paper will describe the studies of our group and other investigators supporting this pathophysiological hypothesis, as well as its implications for early detection and therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K., Ventura, J., McFarlane, W., Perkins, D. O., Pearlson, G. D., & Woods, S. W. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007040 · Cited by 1,798
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483
Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1785 · Cited by 1,346
Self-citationCannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Self-citationLisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Self-citationReversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Duration of psychosis and outcome in first-episode schizophrenia
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1183 · Cited by 880
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Self-citationNeuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
Pruessner, J. C. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.4.433 · Cited by 706
Harrison, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1761-y · Cited by 693
Metabolism and role of glutamate in mammalian brain
Erecińska, M., & Silver, I. A. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90013-7 · Cited by 682
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593
Self-citationKetamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
Heckers, S., Rauch, S., Goff, D., Savage, C., Schacter, D., Fischman, A., & Alpert, N. (1998) · Nature Neuroscience · doi:10.1038/1137 · Cited by 570
Schobel, S. A., Chaudhury, N. H., Khan, U. A., Paniagua, B., Styner, M. A., Asllani, I., Inbar, B. P., Corcoran, C. M., Lieberman, J. A., Moore, H., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.011 · Cited by 549
Self-citationBogerts, B., Ashtari, M., Degreef, G., Alvir, J. M. J., Bilder, R. M., & Lieberman, J. A. (1990) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(90)90004-p · Cited by 544
Self-citationImpaired recruitment of the hippocampus during conscious recollection in schizophrenia
Heckers, S., Rauch, S. L., Goff, D., Savage, C. R., Schacter, D. L., Fischman, A. J., & Alpert, N. M. (1998) · NeuroImage · doi:10.1016/s1053-8119(18)30930-3 · Cited by 492
Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
Lieberman, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00147-x · Cited by 483
Self-citationHippocampal morphometry in schizophrenia by high dimensional brain mapping
Csernansky, J. G., Joshi, S., Wang, L., Haller, J. W., Gado, M., Miller, J. P., Grenander, U., & Miller, M. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11406 · Cited by 470
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman, J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170047006 · Cited by 442
Self-citationKetamine activates psychosis and alters limbic blood flow in schizophrenia
Lahti, A. C., Holcomb, H. H., Medoff, D. R., & Tamminga, C. A. (1995) · NeuroReport · doi:10.1097/00001756-199504190-00011 · Cited by 434
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Andreasen, N. C., Nopoulos, P., Magnotta, V., Pierson, R., Ziebell, S., & Ho, B.-C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.017 · Cited by 373
Gao, X.-M., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., & Tamminga, C. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1141 · Cited by 372
Schobel, S. A., Lewandowski, N. M., Corcoran, C. M., Moore, H., Brown, T., Malaspina, D., & Small, S. A. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.115 · Cited by 364
Self-citationParvalbumin-Positive Basket Cells Differentiate among Hippocampal Pyramidal Cells
Lee, S.-H., Marchionni, I., Bezaire, M., Varga, C., Danielson, N., Lovett-Barron, M., Losonczy, A., & Soltesz, I. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.034 · Cited by 358
Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00039-9 · Cited by 353
Rothman, D. L., Behar, K. L., Hyder, F., & Shulman, R. G. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142131 · Cited by 337
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329
Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M., Walker, E. F., Woods, S. W., et al. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl075 · Cited by 298
Mao, X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1519 · Cited by 296
Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295
Immunotherapeutic Approaches for Alzheimer’s Disease
Wisniewski, T., & Goñi, F. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.064 · Cited by 284
GABAergic mechanisms of hippocampal hyperactivity in schizophrenia
Heckers, S., & Konradi, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.041 · Cited by 277
Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1982-8 · Cited by 272
Cartmell, J., Monn, J. A., & Schoepp, D. D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35084-0 · Cited by 269
Neuroenergetics: Calling Upon Astrocytes to Satisfy Hungry Neurons
Pellerin, L., & Magistretti, P. J. (2004) · The Neuroscientist · doi:10.1177/1073858403260159 · Cited by 267
Regional specificity of hippocampal volume reductions in first-episode schizophrenia
Narr, K. L., Thompson, P. M., Szeszko, P., Robinson, D., Jang, S., Woods, R. P., Kim, S., Hayashi, K. M., Asunction, D., Toga, A. W., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.11.011 · Cited by 263
Probing the human hippocampus using rCBF: Contrasts in schizophrenia
Medoff, D. R., Holcomb, H. H., Lahti, A. C., & Tamminga, C. A. (2001) · Hippocampus · doi:10.1002/hipo.1070 · Cited by 257
Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
Harrison, P. J., McLaughlin, D., & Kerwin, R. W. (1991) · The Lancet · doi:10.1016/0140-6736(91)93392-m · Cited by 238
Fuente-Sandoval, C. D. L., León-Ortiz, P., Favila, R., Stephano, S., Mamo, D., Ramírez-Bermúdez, J., & Graff-Guerrero, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.65 · Cited by 233
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227
Keilhoff, G., Becker, A., Grecksch, G., Wolf, G., & Bernstein, H.-G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.039 · Cited by 199
Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data
Jia, P., Wang, L., Meltzer, H. Y., & Zhao, Z. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.001 · Cited by 196
Statistical shape analysis of neuroanatomical structures based on medial models
Styner, M., Gerig, G., Lieberman, J., Jones, D., & Weinberger, D. (2003) · Medical Image Analysis · doi:10.1016/s1361-8415(02)00110-x · Cited by 195
Self-citationIncreased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Kraguljac, N. V., White, D. M., Reid, M. A., & Lahti, A. C. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2437 · Cited by 191
Implementing Coordinated Specialty Care for Early Psychosis: The RAISE Connection Program
Dixon, L. B., Goldman, H. H., Bennett, M. E., Wang, Y., McNamara, K. A., Mendon, S. J., Goldstein, A. B., Choi, C.-W. J., Lee, R. J., Lieberman, J. A., et al. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400281 · Cited by 190
Self-citationMorphological maturation of the mouse brain: An in vivo MRI and histology investigation
Hammelrath, L., Škokić, S., Khmelinskii, A., Hess, A., van der Knaap, N., Staring, M., Lelieveldt, B. P. F., Wiedermann, D., & Hoehn, M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.009 · Cited by 185
Recent genetic findings in schizophrenia and their therapeutic relevance
Harrison, P. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114553647 · Cited by 183
Kendler, K. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.50 · Cited by 178
Evidence for altered trisynaptic circuitry in schizophrenic hippocampus
Benes, F. M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00136-5 · Cited by 170
Wilson, G. M., Flibotte, S., Chopra, V., Melnyk, B. L., Honer, W. G., & Holt, R. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi489 · Cited by 167
Resting neural activity distinguishes subgroups of schizophrenia patients
Malaspina, D., Harkavy-Friedman, J., Corcoran, C., Mujica-Parodi, L., Printz, D., Gorman, J. M., & Van Heertum, R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.013 · Cited by 165
Self-citationHolcomb, H. H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00229-9 · Cited by 157
Progression from selective to general involvement of hippocampal subfields in schizophrenia
Ho, N. F., Iglesias, J. E., Sum, M. Y., Kuswanto, C. N., Sitoh, Y. Y., de Souza, J., Hong, Z., Fischl, B. R., Roffman, J. L., Zhou, J. H., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.4 · Cited by 154
Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia
Harrison, P. J., Law, A. J., & Eastwood, S. L. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.006 · Cited by 144
Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†
Greene, R. (2001) · Hippocampus · doi:10.1002/hipo.1072 · Cited by 140
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
Chakos, M., Schobel, S., Gu, H., Gerig, G., Bradford, D. W., Charles, C. H., & Lieberman, J. A. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.1.26 · Cited by 136
Self-citationRaichle, M. E. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.001341 · Cited by 124
The psychosis high-risk state: A comprehensive state-of-the-art review
Fusar‐Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher‐Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · Bern Open Repository and Information System (University of Bern) · Cited by 113
Matrisciano, F., Tueting, P., Maccari, S., Nicoletti, F., & Guidotti, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.274 · Cited by 110
Schobel, S., Kelly, M. A., Corcoran, C. M., Heertum, K. V., Seckinger, R. A., Goetz, R. R., Harkavy‐Friedman, J., & Malaspina, D. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.016 · Cited by 105
Self-citationKraguljac, N. V., Frölich, M. A., Tran, S., White, D. M., Nichols, N., Barton-McArdle, A., Reid, M. A., Bolding, M., & Lahti, A. C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.122 · Cited by 105
Gonzalez, R. G., Fischman, A. J., Guimarães, A. R., Carr, C. A., Stern, C. E., Halpern, E. F., Growdon, J. H., & Rosen, B. R. (1995) · PubMed · Cited by 103
Kühn, S., Musso, F., Mobascher, A., Warbrick, T., Winterer, G., & Gallinat, J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.51 · Cited by 91
Coultrap, S. J., Nixon, K. M., Alvestad, R. M., Valenzuela, C. F., & Browning, M. D. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.005 · Cited by 90
Gaisler-Salomon, I., Miller, G. M., Chuhma, N., Lee, S., Zhang, H., Ghoddoussi, F., Lewandowski, N., Fairhurst, S., Wang, Y., Conjard-Duplany, A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.58 · Cited by 86
Self-citation13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90073-z · Cited by 84
Adams, D. H., Zhang, L., Millen, B. A., Kinon, B. J., & Gómez, J. (2014) · Schizophrenia Research and Treatment · doi:10.1155/2014/758212 · Cited by 78
Imre, G., Salomons, A. R., Jongsma, M. E., Fokkema, D. S., den Boer, J. A., & Horst, G. J. T. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.021 · Cited by 66
Regional cerebral blood flow in patients with schizophrenia: A preliminary report
Kawasaki, Y., Suzuki, M., Maeda, Y., Urata, K., Yamaguchi, N., Matsuda, H., Hisada, K., Suzuki, M., & Takashima, T. (1992) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190252 · Cited by 63
Vutskits, L., Gascon, E., Potter, G., TASSONYI, E., & Kiss, J. Z. (2007) · Toxicology · doi:10.1016/j.tox.2007.03.004 · Cited by 63
Regional brain volume change over the life-time course of schizophrenia
DeLisi, L. E. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00028-x · Cited by 58
de Lima, A. D., Opitz, T., & Voigt, T. B. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03403.x · Cited by 58
Small, S. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.030 · Cited by 55
Self-citationDifferent Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome
Green, I. W., & Glausier, J. R. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv136 · Cited by 46
Proposed cycles for functional glutamate trafficking in synaptic neurotransmission
Maciejewski, P. K., & Rothman, D. L. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.09.015 · Cited by 45
Molina, V., Reig, S., Pascau, J., Sanz, J., Sarramea, F., Gispert, J. D., Luque, R., Benito, C., Palomo, T., & Desco, M. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(03)00107-0 · Cited by 44
Risk genes for schizophrenia: Translational opportunities for drug discovery
Winchester, C. L., Pratt, J. A., & MORRIS, B. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.003 · Cited by 32
Two-stage empirical likelihood for longitudinal neuroimaging data
Shi, X., Ibrahim, J. G., Lieberman, J. A., Styner, M. A., Li, Y., & Hongtu Zhu, B. (2011) · The Annals of Applied Statistics · doi:10.1214/11-aoas480 · Cited by 8
Self-citationThe impossible dream: can psychiatry prevent psychosis?
Lieberman, J. A., & Corcoran, C. M. (2007) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2007.00031.x · Cited by 6
Self-citation
Cited by
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Opel, N., Goltermann, J., Hermesdorf, M., Berger, K., Baune, B. T., & Dannlowski, U. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.04.027 · Cited by 293
Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
Alnæs, D., Kaufmann, T., van der Meer, D., Córdova-Palomera, A., Rokicki, J., Moberget, T., Bettella, F., Agartz, I., Barch, D. M., Bertolino, A., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0257 · Cited by 264
Gogos, A., Ney, L. J., Seymour, N., Van Rheenen, T. E., & Felmingham, K. L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14584 · Cited by 189
Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01515-3 · Cited by 55
Metadata
- Authors
- Lieberman, J. A., Girgis, R. R., Brucato, G., Moore, H., Provenzano, F., Kegeles, L., Javitt, D., Kantrowitz, J., Wall, M. M., Corcoran, C. M., Schobel, S. A., & Small, S. A.
- Venue
- Molecular Psychiatry
- Published
- 2018-01-09
- Volume
- 23
- Issue
- 8
- Pages
- 1764-1772
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2783894827
- Cited by
- 376
- References
- 90
- FWCI
- 23.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.